OBIO NASDAQ
Orchestra BioMed Holdings, Inc.
1W: +0.0%
1M: +20.2%
3M: +45.8%
YTD: +38.0%
1Y: +133.3%
3Y: -25.0%
5Y: -40.1%
$5.95
-0.40 (-6.30%)
Weekly Expected Move ±8.8%
$5
$5
$6
$6
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-10-21
Earliest Filing
2025-10-28
Latest Filing
investor: 8
partner: 2
target: 1
Counterparties (Filed by OBIO)
11 relationshipsCompanies named in OBIO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Terumo Medical Corporation | — | partner | Partner in Termination and ROFR Agreement and investor in Series A Preferred Stock | 2025-10-28 | View |
| Terumo Corporation | — | partner | Partner in Termination and ROFR Agreement and investor in Series A Preferred Stock | 2025-10-28 | View |
| Ligand Pharmaceuticals Incorporated | LGNZZ | investor | PIPE investor and warrant recipient in private placement | 2025-08-04 | View |
| Medtronic plc | MDT | investor | Parent company of affiliate Covidien Group S.à.r.l., a PIPE investor | 2025-08-04 | View |
| Ligand Pharmaceuticals Incorporated | LGNZZ | investor | Purchased revenue participation rights and shares in a private placement. | 2025-07-31 | View |
| Covidien Group S.à.r.l. | — | investor | Affiliate of Medtronic that purchased shares in a private placement. | 2025-07-31 | View |
| Orchestra BioMed, Inc. | OBIO | target | Target company in the business combination with HSAC2 | 2022-10-21 | View |
| RTW Investments, LP | — | investor | Investor providing backstop and forward purchase commitments | 2022-10-21 | View |
| RTW Master Fund, Ltd. | — | investor | Fund listed as a party to the amended agreements | 2022-10-21 | View |
| RTW Innovation Master Fund, Ltd. | — | investor | Fund listed as a party to the amended agreements | 2022-10-21 | View |
| RTW Venture Fund Limited | — | investor | Fund listed as a party to the amended agreements | 2022-10-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-01 | Regulation FD; Other Events; Exhibits | View | |
| 2026-09-08 | Regulation FD; Exhibits | View | |
| 2026-06-23 | Shareholder Vote | View | |
| 2026-02-13 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-01-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-10-30 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-10-28 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Unregistered | Agreement | View |
| 2025-08-04 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Other Events; Financial Statemen | Agreement | View |
| 2025-07-31 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-06-24 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-04-29 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-03-03 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-02-25 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-02-05 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-08-12 | Other Events; Financial Statements and Exhibits | View | |
| 2024-07-30 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-06-11 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-03-29 | Other Events | View | |
| 2024-03-07 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR